Cargando…

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion

Xp11 translocation renal cell carcinoma (RCC), a member of the microphthalmia-associated transcription factor (MiTF) family, is a rare renal tumor characterized by different translocations involving the TFE3 gene. Here, we reported a case of Xp11 translocation RCC with a rare MED15-TFE3 gene fusion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Hong, Qin, Shuming, Li, Ning, Lin, Min, Xu, Yanmei, Li, Xiaomei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881588/ https://www.ncbi.nlm.nih.gov/pubmed/31828108 http://dx.doi.org/10.1155/2019/5974089

Ejemplares similares

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
por: Ge, Yan, et al.
Publicado: (2021)

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
por: Huang, Wenpeng, et al.
Publicado: (2023)

Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Wang, Wei, et al.
Publicado: (2014)

Dynamic Contrast-Enhanced CT Characterization of Xp11.2 Translocation/TFE3 Gene Fusions versus Papillary Renal Cell Carcinomas
por: He, Jian, et al.
Publicado: (2015)

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
por: Zhang, Huizhi, et al.
Publicado: (2023)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature
por: Ahluwalia, Puneet, et al.
Publicado: (2013)

Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature
por: Gong, Pengfeng, et al.
Publicado: (2018)

Newly Designed Break-Apart and ASPL-TFE3 Dual-Fusion FISH Assay Are Useful in Diagnosing Xp11.2 Translocation Renal Cell Carcinoma and ASPL-TFE3 Renal Cell Carcinoma: A STARD-Compliant Article
por: Chen, Xiancheng, et al.
Publicado: (2015)

Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies
por: Cheng, Xiangming, et al.
Publicado: (2016)

Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2022)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
por: Agizamhan, Sezim, et al.
Publicado: (2018)

Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma
por: Cheng, Jun, et al.
Publicado: (2020)

The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma
por: Liu, Ning, et al.
Publicado: (2020)

Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) – A Case Study and Review of the Literature
por: Miroński, Ignacy, et al.
Publicado: (2022)

The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma
por: Naviwala, Mohammad Saad, et al.
Publicado: (2023)

TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas
por: Yin, Xiaoqin, et al.
Publicado: (2019)

Temsirolimus in the treatment of renal cell carcinoma associated with Xp11.2 translocation/TFE gene fusion proteins: a case report and review of literature
por: Parikh, Jigarkumar, et al.
Publicado: (2009)

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma
por: Dong, Xiang, et al.
Publicado: (2022)

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma
por: Pei, Jianming, et al.
Publicado: (2019)

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
por: Sun, Guangxi, et al.
Publicado: (2021)

Emerging roles of TFE3 in metabolic regulation
por: Li, Xingyu, et al.
Publicado: (2023)

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue
por: Xiong, Lei, et al.
Publicado: (2017)

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma
por: Pradhan, Dinesh, et al.
Publicado: (2015)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements
por: Lee, Seok Joo, et al.
Publicado: (2016)

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report
por: Zhao, Juping, et al.
Publicado: (2022)

TFEB and TFE3 drive kidney cystogenesis and tumorigenesis
por: Di Malta, Chiara, et al.
Publicado: (2023)

Nuclear translocation of TFE3 under hypoxia enhances the engraftment of human hematopoietic stem cells
por: Wang, Xuepeng, et al.
Publicado: (2022)

Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
por: Wei, Shuping, et al.
Publicado: (2019)

TFE3-Expressing Perivascular Epithelioid Cell Tumor of the Breast
por: Kim, Hyunjin, et al.
Publicado: (2019)

Hepatic YAP1-TFE3 Rearranged Epithelioid Hemangioendothelioma
por: Lotfalla, Mira M., et al.
Publicado: (2019)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: He, Xin, et al.
Publicado: (2021)

TFE3 is a Novel Biomarker of Ovarian Sclerosing Stromal Tumours
por: Zhao, Li, et al.
Publicado: (2023)

Uterine PEComas: Correlation Between Melanocytic Marker Expression and TSC Alterations/TFE3 Fusions
por: Bennett, Jennifer A., et al.
Publicado: (2022)

MiT/TFE Family Renal Cell Carcinoma
por: Tang, Jinglong, et al.
Publicado: (2023)

TFE3 regulates whole‐body energy metabolism in cooperation with TFEB
por: Pastore, Nunzia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bn70uglso0b4a5uo0e2kfhvl83